Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Panacea Biotec Limited ( (IN:PANACEABIO) ) just unveiled an update.
Panacea Biotec Limited announced the superannuation of Mr. Sunil Anand, the Associate Director – Finance & Corporate Affairs, effective March 31, 2025. Mr. Anand’s departure marks the end of over two decades of service, during which he played a crucial role in the company’s growth. The management expressed deep appreciation for his contributions, indicating a significant transition in the company’s senior management team.
More about Panacea Biotec Limited
Panacea Biotec Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of a range of pharmaceutical formulations and vaccines. The company is known for its contributions to healthcare and has a significant presence in both domestic and international markets.
YTD Price Performance: 0.49%
Average Trading Volume: 22,748
Current Market Cap: 26.99B INR
Learn more about PANACEABIO stock on TipRanks’ Stock Analysis page.